Jellyfish Protein May Treat Neurodegenerative Diseases
Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics on October 29, 2006
Scientists have isolated aequorin, a protein from jellyfish which have neuroprotective propoerties and may hold promise in treating neurodegenerative diseases, such as Alzheimer's disease.
Its putative mechanism of action is by controlling calcium levels in the neurons.
Diseases like Alzheimer's are associated with a loss of "calcium-binding" proteins that protect nerve cells, said Moyer. Calcium is necessary for communication between neurons in the brain, and learning and memory are not possible without it. But too much of it leads to neuron death, interfering with memory and contributing to neurodegenerative diseases.Calcium-binding proteins decline with age, however, limiting the brain's ability to control or handle the amount of calcium "allowed in."
Aequorin, the jellyfish protein, appears to be a viable substitute.
Preliminary laboratory test results have been presented by Quincy Bioscience during the 2006 Bio Conference in Chicago. To view a video presentation discussing aequorin and its potentials, go to mediasite.com, click BIO2006 on the left panel and type in "Quincy" in the Find Presentation box.
[Image: Ribbon diagram of the crystal structure of Aequorin from PDB entry 1EJ3 (Assumed biological molecule).]

Aequorin, the jellyfish protein, appears to be a viable substitute.
Tags: neuroscience alzheimers+disease jellyfish alzheimer biotech neurodegenerative+diseases jellyfish+pro
Vote for Jellyfish Protein May Treat Neurodegenerative Diseases:
|
Rating: 9.80 out of 5 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
